These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9421395)
1. Osteocalcin production in primary osteoblast cultures derived from normal and Hyp mice. Carpenter TO; Moltz KC; Ellis B; Andreoli M; McCarthy TL; Centrella M; Bryan D; Gundberg CM Endocrinology; 1998 Jan; 139(1):35-43. PubMed ID: 9421395 [TBL] [Abstract][Full Text] [Related]
2. Osteocalcin abnormalities in Hyp mice reflect altered genetic expression and are not due to altered clearance, affinity for mineral, or ambient phosphorus levels. Carpenter TO; Gundberg CM Endocrinology; 1996 Dec; 137(12):5213-9. PubMed ID: 8940337 [TBL] [Abstract][Full Text] [Related]
3. Human and murine osteocalcin gene expression: conserved tissue restricted expression and divergent responses to 1,25-dihydroxyvitamin D3 in vivo. Sims NA; White CP; Sunn KL; Thomas GP; Drummond ML; Morrison NA; Eisman JA; Gardiner EM Mol Endocrinol; 1997 Oct; 11(11):1695-708. PubMed ID: 9328351 [TBL] [Abstract][Full Text] [Related]
4. Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes. Clemens TL; Tang H; Maeda S; Kesterson RA; Demayo F; Pike JW; Gundberg CM J Bone Miner Res; 1997 Oct; 12(10):1570-6. PubMed ID: 9333117 [TBL] [Abstract][Full Text] [Related]
5. Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3. Lohmann CH; Bonewald LF; Sisk MA; Sylvia VL; Cochran DL; Dean DD; Boyan BD; Schwartz Z J Bone Miner Res; 2000 Jun; 15(6):1169-80. PubMed ID: 10841186 [TBL] [Abstract][Full Text] [Related]
6. Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice. Ecarot B; Glorieux FH; Desbarats M; Travers R; Labelle L J Bone Miner Res; 1995 Mar; 10(3):424-31. PubMed ID: 7785464 [TBL] [Abstract][Full Text] [Related]
7. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression. Lian JB; Shalhoub V; Aslam F; Frenkel B; Green J; Hamrah M; Stein GS; Stein JL Endocrinology; 1997 May; 138(5):2117-27. PubMed ID: 9112412 [TBL] [Abstract][Full Text] [Related]
8. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I. Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788 [TBL] [Abstract][Full Text] [Related]
9. Abnormal modulation of serum osteocalcin by dietary phosphate and 1,25-dihydroxyvitamin D3 in the hypophosphatemic mouse. Tsuji H; Cawthorn C; Ecarot B J Bone Miner Res; 1996 Sep; 11(9):1234-40. PubMed ID: 8864897 [TBL] [Abstract][Full Text] [Related]
10. 1,25-(OH)2D3 down-regulates expression of Phex, a marker of the mature osteoblast. Ecarot B; Desbarats M Endocrinology; 1999 Mar; 140(3):1192-9. PubMed ID: 10067843 [TBL] [Abstract][Full Text] [Related]
11. Abnormal response of osteoblasts from Hyp mice to 1,25-dihydroxyvitamin D3. Yamamoto T; Ecarot B; Glorieux FH Bone; 1992; 13(3):209-15. PubMed ID: 1322149 [TBL] [Abstract][Full Text] [Related]
12. Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers. Ruchon AF; Tenenhouse HS; Marcinkiewicz M; Siegfried G; Aubin JE; DesGroseillers L; Crine P; Boileau G J Bone Miner Res; 2000 Aug; 15(8):1440-50. PubMed ID: 10934642 [TBL] [Abstract][Full Text] [Related]
13. Posttranscriptional regulation of osteocalcin mRNA in clonal osteoblast cells by 1,25-dihydroxyvitamin D3. Mosavin R; Mellon WS Arch Biochem Biophys; 1996 Aug; 332(1):142-52. PubMed ID: 8806719 [TBL] [Abstract][Full Text] [Related]
14. Comparison of 22-oxacalcitriol and 1,25(OH)2D3 on bone metabolism in young X-linked hypophosphatemic male mice. Halstead LR; Weinstein RS; Cheng SL; Rifas L; Avioli LV Am J Physiol; 1996 Jan; 270(1 Pt 1):E141-7. PubMed ID: 8772486 [TBL] [Abstract][Full Text] [Related]
15. The human osteocalcin promoter directs bone-specific vitamin D-regulatable gene expression in transgenic mice. Kesterson RA; Stanley L; DeMayo F; Finegold M; Pike JW Mol Endocrinol; 1993 Mar; 7(3):462-7. PubMed ID: 8483481 [TBL] [Abstract][Full Text] [Related]
16. Direct demonstration of a humorally-mediated inhibition of renal phosphate transport in the Hyp mouse. Lajeunesse D; Meyer RA; Hamel L Kidney Int; 1996 Nov; 50(5):1531-8. PubMed ID: 8914019 [TBL] [Abstract][Full Text] [Related]
17. Differentiation of heterogeneous phenotypes in human osteoblast cultures in response to 1,25-dihydroxyvitamin D3. Thavarajah M; Evans DB; Kanis JA Bone; 1993; 14(5):763-7. PubMed ID: 7505605 [TBL] [Abstract][Full Text] [Related]
18. Increased cathepsin D release by Hyp mouse osteoblast cells. Matsumoto N; Jo OD; Shih RN; Brochmann EJ; Murray SS; Hong V; Yanagawa J; Yanagawa N Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E123-32. PubMed ID: 15958652 [TBL] [Abstract][Full Text] [Related]
19. 1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Scharla SH; Strong DD; Mohan S; Baylink DJ; Linkhart TA Endocrinology; 1991 Dec; 129(6):3139-46. PubMed ID: 1720089 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of 1,25(OH)2 vitamin D3 on collagen type I, osteopontin, and osteocalcin gene expression in chicken osteoblasts. Broess M; Riva A; Gerstenfeld LC J Cell Biochem; 1995 Mar; 57(3):440-51. PubMed ID: 7768979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]